COLTHARP DOUGLAS E 4

What Happened Douglas E. Coltharp, Chief Financial Officer of Encompass Health Corp (EHC), was issued a total of 42,018 restricted shares in two award transactions: 37,588 shares on 2026-02-18 and 4,430 shares on 2026-02-19. The reported acquisition price for both issuances is $0.00, reflecting grants of restricted stock rather than open-market purchases or cash exercises.

Key Details

• Transaction type: A = Award/Grant (restricted stock issuance)
• Dates and amounts: 2026-02-18 — 37,588 shares; 2026-02-19 — 4,430 shares (total 42,018)
• Reported price: $0.00 per share (awarded, not purchased)
• Shares owned after transaction: not specified in the filing
• Footnotes: F1 — issuance of restricted stock from satisfaction of performance criteria under a Feb 23, 2023 performance share unit award; F2 — annual restricted stock award under the 2025 Omnibus Performance Incentive Plan
• Filing timeliness: Form 4 filed 2026-02-20 (timely given the reporting window)

Context These transactions are award-based grants of restricted stock, not open-market buys or sales. Restricted shares granted for performance or as annual compensation typically carry vesting or transfer restrictions and do not necessarily signal immediate trading intent. For retail investors, awards show compensation alignment with company performance but are not the same as an insider personally buying stock on the market.